On Monday, Shares of Rite Aid Corporation (NYSE:RAD), dropped -1.94% to $8.09.
As the number of pertussis (also known as whooping cough) cases enhances, Rite Aid is encouraging Washington residents to get vaccinated against the disease if they haven’t already done so. Rite Aid pharmacists are readily accessible to administer the whooping cough vaccine, Tdap, at all 139 Washington locations. Last week, the Washington State Department of Health stated an enhance in the number of pertussis (whooping cough) cases this year. There have been 319 cases of whooping cough so far in 2015 – a 551 percent enhance in number of cases from 2014.
The Centers for Disease Control and Prevention recommends adolescents 11 and above receive the Tdap vaccine. Cost varies based on the patient’s insurance coverage and the Tdap vaccines are covered by many insurance plans. Tdap vaccinations are accessible during pharmacy hours and no appointment is necessary. To locate the nearest Rite Aid pharmacy, visit www.riteaid.com or call 1-800-RITE-AID.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.
Shares of Pfizer Inc. (NYSE:PFE), declined -1.93% to $34.59, during its last trading session.
The board of directors of Pfizer, declared a 28-cent second-quarter 2015 dividend on the company’s common stock, payable June 2, 2015, to shareholders of record at the close of business on May 8, 2015. The second-quarter 2015 cash dividend will be the 306th successive quarterly dividend paid by Pfizer.
Preliminary results from the Annual Meeting of Shareholders held recently indicate that the company’s 11 director nominees were re-elected to one-year terms and that shareholders ratified the selection of KPMG LLP as Pfizer’s independent registered public accounting firm for the 2015 fiscal year. In addition, shareholders voted in support of the board-sponsored proposal to approve, on an advisory basis, the compensation of the company’s named executive officers.
In other voting, a shareholder proposal was not approved by the shareholders.
The final results are subject to verification by the independent election inspectors. The final results will be stated on a Form 8-K to be filed by Pfizer with the Securities and Exchange Commission in the next few days.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
At the end of Monday’s trade, Shares of NQ Mobile Inc. (NYSE:NQ), dwindled -1.90% to $4.12.
NQ Mobile, declared that Mr. Omar Khan, current Co-Chief Executive Officer of NQ Mobile, has decided to transition to an advisory role and step down in his capacity as Co-CEO and Director of the Company, effective as of May 1, 2015. At the same time, Mr. Khan will also resign from his position as the Chief Executive Officer of NQ Mobile US, Inc., a direct wholly owned partner of the Company, and from his other roles within the Company. To assist with a smooth transition, Mr. Khan will remain with the Company as an advisor through December 31, 2015.
As part of this transition, in order to streamline the administration process of the Company, the Company will also eliminate the Co-CEO administration structure. The Board of Directors has decided to appoint Mr. Zemin Xu, the current Co-CEO of the Company, to take over as the Company’s Chief Executive Officer, effective as of May 1, 2015.
NQ Mobile Inc. provides mobile Internet services in the People’s Republic of China and internationally. The company provides products and services in the areas of mobile security, privacy, productivity, personalized cloud, and family protection. It operates through two segments, Consumer and Enterprise.
Finally, Rex Energy Corporation (NASDAQ:REXX), ended its last trade with -1.90% loss, and closed at $4.65.
Rex Energy, declared plans to release first quarter 2015 financial and operational results on Tuesday, May 5, 2015 after market close. Administration will host a live conference call and webcast on Wednesday, May 6, 2015 at 10 a.m. ET to review first quarter financial results and operational highlights. Reference material for the conference call and webcast will be posted to the company’s website preceding to the call.
Rex Energy Corporation operates as an independent oil, natural gas liquid, and natural gas company in the Appalachian and Illinois basins in the United States. The company focuses on the Marcellus Shale, Utica Shale, and Burkett Shale drilling and exploration activities in the Appalachian Basin, in addition to on developmental oil drilling and the implementation of improved oil recovery on its properties in the Illinois Basins.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
